Evidence map›Paper›PMID 36927522›Full record

ArticleGut microbes

Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes.

Laila Silamiķele, Rihards Saksis, Ivars Silamiķelis, Patrīcija Paulīne Kotoviča, Monta Brīvība, Ineta Kalniņa, Zane Kalniņa, Dāvids Fridmanis, Jānis Kloviņš

Open access · goldFull text read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Laila SilamiķeleHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Rihards SaksisHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Ivars SilamiķelisHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Patrīcija Paulīne KotovičaHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Monta BrīvībaHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Ineta KalniņaHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Zane KalniņaHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Dāvids FridmanisHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Jānis KloviņšHuman genetics and disease mechanisms, Latvian Biomedical Research and Study Centre, Riga, Latvia.ORCID 0000-0001-8362-5505
Latvian Biomedical Research and Study Centre · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antidiabetic drug metformin alters the gut microbiome composition in the context of type 2 diabetes and other diseases; however, its effects have been mainly studied using fecal samples, which offer limited information about the intestinal site-specific effects of this drug. Our study aimed to characterize the spatial variation of the gut microbiome in response to metformin treatment by using a high-fat diet-induced type 2 diabetes mouse model of both sexes. Four intestinal parts, each at the luminal and mucosal layer level, were analyzed in this study by performing 16S rRNA sequencing covering six variable regions (V1-V6) of the gene and thus allowing to obtain in-depth information about the microbiome composition. We identified significant differences in gut microbiome diversity in each of the intestinal parts regarding the alpha and beta diversities. Metformin treatment altered the abundance of different genera in all studied intestinal sites, with the most pronounced effect in the small intestine, where

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeMetforminAnimalsDiet, High-FatDisease Models, AnimalFemaleMaleMiceRNA, Ribosomal, 16SMetforminRNA, Ribosomal, 16S16S rRNA sequencingC57BL/6Ngut microbiomehigh-fat dietintestinal partslumen and mucosaMetformin

Identifiers

PMID36927522
PMCPMC10026874
OpenAlexW4327685814

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read12
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.